Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Motoki Tamai"'
Autor:
Wataru Fukumoto, Shunsuke Okamura, Motoki Tamai, Junya Arima, Ichiro Kawahara, Ikumi Fukuda, Akihiko Mitsuke, Takashi Sakaguchi, Satoshi Sugita, Ryosuke Matsushita, Shuichi Tatarano, Yasutoshi Yamada, Masayuki Nakagawa, Hideki Enokida, Hirofumi Yoshino
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background Chemotherapy including cisplatin is recommended for the treatment of advanced bladder cancer, but its effectiveness is limited due to the acquisition of drug resistance. Although several mechanisms of cisplatin resistance have bee
Externí odkaz:
https://doaj.org/article/7d46651dce6b448899636a311a74c173
Autor:
Hirofumi Yoshino, Seiya Yokoyama, Motoki Tamai, Shunsuke Okamura, Sayaka Iizasa, Takashi Sakaguchi, Yoichi Osako, Satoru Inoguchi, Ryosuke Matsushita, Yasutoshi Yamada, Masayuki Nakagawa, Shuichi Tatarano, Akihide Tanimoto, Hideki Enokida
Publikováno v:
FEBS Open Bio, Vol 13, Iss 6, Pp 1056-1066 (2023)
Combination chemotherapy with gemcitabine and cisplatin (GC) is recommended as the primary treatment for advanced bladder cancer (BC). However, the benefits of this approach are limited owing to the acquisition of drug resistance. Here, we found that
Externí odkaz:
https://doaj.org/article/720e8450134c49778a8939c7650a0022
Autor:
Motoki Tamai, Shuichi Tatarano, Shunsuke Okamura, Wataru Fukumoto, Issei Kawakami, Yoichi Osako, Takashi Sakaguchi, Satoshi Sugita, Masaya Yonemori, Yasutoshi Yamada, Masayuki Nakagawa, Hideki Enokida, Hirofumi Yoshino
Publikováno v:
Molecular Oncology, Vol 16, Iss 6, Pp 1329-1346 (2022)
Patients with advanced bladder cancer are generally treated with a combination of chemotherapeutics, including gemcitabine, but the effect is limited due to acquisition of drug resistance. Thus, in this study, we investigated the mechanism of gemcita
Externí odkaz:
https://doaj.org/article/c55b1c48d9a940969d81190a0f2acebb
Autor:
Yusuke Hamamoto, Tomohisa Nagasao, Niyazi Aizezi, Motoki Tamai, Tetsukuni Kogure, Tadaaki Morotomi, Noriyuki Tagichi, Yoshio Tanaka
Publikováno v:
JPRAS Open, Vol 18, Iss , Pp 28-37 (2018)
Purpose: This study aims to clarify whether normobaric oxygen therapy improves the survival of auricular composite grafts in rats. Methods: For 10 male SD rats, 1.5 cm2 composite grafts were harvested from bilateral ear regions including whole auricl
Externí odkaz:
https://doaj.org/article/15eeabb3aec64b9eaef9cdae436f0af5
Autor:
Tomohisa Nagasao, Tadaaki Morotomi, Motone Kuriyama, Motoki Tamai, Yoshiaki Sakamoto, Naoki Takano
Publikováno v:
Computer Assisted Surgery, Vol 23, Iss 1, Pp 1-7 (2018)
Purpose: Detection of optic canal fractures is often difficult because of the subtleness of the fracture. If we could clarify impact on which region around the orbit is likely to accompany the fracture of the optic canal, the knowledge should be usef
Externí odkaz:
https://doaj.org/article/daa19e0a750f461c86d14fad54bc2758
Publikováno v:
Journal of Plastic, Reconstructive & Aesthetic Surgery. 76:4-9
In the standard Nuss procedure for pectus excavatum, the costal arch is often elevated together with the sternum, resulting in unevenness of the lower part of the thorax. This complication is commonly called rib flaring. This paper presents a techniq
Autor:
Hirofumi Yoshino, Shuichi Tatarano, Motoki Tamai, Masafumi Tsuruda, Sayaka Iizasa, Junya Arima, Issei Kawakami, Wataru Fukumoto, Ichiro Kawahara, Gang Li, Takashi Sakaguchi, Satoru Inoguchi, Yasutoshi Yamada, Hideki Enokida
Publikováno v:
Biochemical and Biophysical Research Communications. 630:71-76
Exosomes are 40-100 nm nano-sized extracellular vesicles and are receiving increasing attention as novel structures that participate in intracellular communication. We previously found that miRNA-1 (miR-1) functions as a tumor suppressor in renal cel
Autor:
Junya Arima, Hirofumi Yoshino, Ichiro Kawahara, Wataru Fukumoto, Issei Kawakami, Motoki Tamai, Shuichi Tatarano, Hideki Enokida
Publikováno v:
Journal of Urology. 209
Autor:
Hirofumi Yoshino, Seiya Yokoyama, Motoki Tamai, Shunsuke Okamura, Sayaka Iizasa, Takashi Sakaguchi, Yoichi Osako, Satoru Inoguchi, Ryosuke Matsushita, Yasutoshi Yamada, Masayuki Nakagawa, Shuichi Tatarano, Akihide Tanimoto, Hideki Enokida
Background Combination chemotherapy with gemcitabine and cisplatin (GC) is recommended as the primary treatment for advanced bladder cancer (BC). However, the benefits of this approach are limited owing to the acquisition of drug resistance. Therefor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6eafdbb6aadd85ce26841b34ac9a5f85
https://doi.org/10.21203/rs.3.rs-2066247/v1
https://doi.org/10.21203/rs.3.rs-2066247/v1
Autor:
Tomohisa, Nagasao, Tomoki, Miyanagi, Motoki, Tamai, Asako, Hatano, Yoshiaki, Sakamoto, Naoki, Takano
Publikováno v:
Eplasty
BACKGROUND: Part of the skull can be lost due to neurosurgical diseases or trauma. Skulls with partial defects can develop different fracture patterns from those of intact skulls. This study aims to clarify the differences. METHODS: A 3-dimensional s